Skip to main content
SpringerLink
Log in

Potent antitumor activity of oncolytic adenovirus expressing C/EBPβ against hepatocellular carcinoma

  • Letter to the Editor
  • Published:
Apoptosis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Freytag SO, Rogulski KR, Paielli DL, Gilbert JD, Kim JH (1998) A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. Hum Gene Ther 9:1323–1333

    Article  CAS  Google Scholar 

  2. Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY et al (2003) An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res 13:481–489

    Article  CAS  Google Scholar 

  3. Ribas A, Dummer R, Puzanov I et al (2017) Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy. Cell 170(6):1109–1119

    Article  CAS  Google Scholar 

  4. Sun L, Fu BB, Liu DG (2005) Systemic delivery of full-length C/EBP beta/liposome complex suppresses growth of human colon cancer in nude mice. Cell Res 15(10):770–776

    Article  CAS  Google Scholar 

  5. Wang H, Wang Y, Sun L, Liu D (2009) Sequences near both termini of the C/EBPbeta mRNA 3' untranslated region are important for its tumor suppression activity. Acta Biochim Biophys Sin (Shanghai) 41(6):456–463

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of the People’s Republic of China (Grant Nos. 81760287, 31700763), Longyuan Youth Fund for Innovation and Entrepreneurship, Major Cultivation Projects in Central Colleges and Universities (31920190045) and Cultivation Project of Innovation Team in Central Colleges and Universities (31920190027) of Northwest Minzu University.

Author information

Authors and Affiliations

  1. Hebi Precision Medical Research Institute, People’s Hospital of Hebi, 412 Hemei Boulevard, Hebi, 458030, Henan Province, China

    Yan Zeng & Hai-zhen Wang

  2. College of Animal Science and Technology, Jilin Provincial Engineering Research Center of Animal Probiotics, Key Lab of Animal Production, Product Quality and Security, Ministry of Education, Jilin Agricultural University, Changchun, 130118, China

    Yan Zeng & Xin Cao

  3. College of Life Science and Engineering, Center for Biomedical Research, Northwet Minzu University, Lanzhou, 730030, China

    Feng-di Li, Jiang-long Du, Yu-jia Xue & Xin Cao

  4. Department of Medical Oncology, People’s Hospital of Hebi, 412 Hemei Boulevard, Hebi, 458030, Henan Province, China

    Jing Liu

Authors
  1. Yan Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Feng-di Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiang-long Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu-jia Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jing Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xin Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hai-zhen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xin Cao or Hai-zhen Wang.

Ethics declarations

Conflict of interest

The authors confirm that there are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zeng, Y., Li, Fd., Du, Jl. et al. Potent antitumor activity of oncolytic adenovirus expressing C/EBPβ against hepatocellular carcinoma. Apoptosis 25, 154–156 (2020). https://doi.org/10.1007/s10495-020-01595-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-020-01595-4

Search

Navigation